Zortix
Sign in
BULLISHIn depth · 4/5

Resilient 5-6% organic growth through cycles

The thesis presented was that Givaudan has demonstrated resilient, non-cyclical organic growth of 5-6%, with no negative years since its IPO, including during 2008-09 and 2020.

Sign in to read the full idea

The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.

NOT INVESTMENT ADVICE · A SUMMARY OF WHAT WAS SAID ON THE PODCAST · VERIFY AGAINST THE SOURCE
Resilient 5-6% organic growth through cycles · Zortix